SpyGlass Pharma, Inc. (SGP): Total Assets

Annual figures by period end, from SEC filings.

$115.87M
As of 2025-12-31
$243.43M
As of 2026-06-30
2024-12-31: $23.32M2025-12-31: $115.87M$115.87M
2024-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$115.87M+396.9%2026-03-26, Balance as of period end
2024-12-31$23.32Mn/a2026-03-26, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
SpyGlass Pharma, Inc. (SGP)2025-12-31$115.87M+396.9%
Sight Sciences, Inc. (SGHT)2025-12-31$115.30M-19.3%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$114.86M+50.8%
Fractyl Health, Inc. (GUTS)2025-12-31$121.40M+12.3%
DarioHealth Corp. (DRIO)2025-12-31$110.08M-7.4%
Utah Medical Products Inc (UTMD)2025-12-31$122.54M0.0%
Iradimed Corp (IRMD)2025-12-31$108.78M+10.6%
Delcath Systems, Inc. (DCTH)2025-12-31$123.63M+61.4%
Alpha Tau Medical Ltd. (DRTS)2025-12-31$105.65M+22.6%

Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗